Molecular formula
C25H20N4O2
47 compounds have this formula on CompoundList.
- Molar mass
- 408.46g/mol
- Monoisotopic mass
- 408.1586Da
- Atoms
- 51
- Elements
- 4
- Rings plus double bonds
- 18
The formula C25H20N4O2 describes a molecule made of 25 carbon atoms, 20 hydrogen atoms, 4 nitrogen atoms and 2 oxygen atoms. It is written in Hill notation: carbon first, then hydrogen, then the other elements in alphabetical order. The formula tells you which atoms are present, not how they are connected, which is why several different chemicals can share it.
Elemental composition
- C Carbon × 2573.51%12.011 × 25 = 300.275 g/mol
- H Hydrogen × 204.94%1.008 × 20 = 20.160 g/mol
- N Nitrogen × 413.72%14.007 × 4 = 56.028 g/mol
- O Oxygen × 27.83%15.999 × 2 = 31.998 g/mol
Look up another formula
Compounds with the formula C25H20N4O2
Isomers we list, best known first. Open one to see its structure, properties, safety data and suppliers.
Showing 1 to 47 of 47 compounds
Devazepide
CAS 103420-77-5C25H20N4O2
Tinodasertib
CAS 1464151-33-4C25H20N4O2
3-(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)-2-phenylquinazolin-4-one
CAS 132088-35-8C25H20N4O2
Ssr161421
CAS 477706-73-3C25H20N4O2
![N-(5-(6-Methoxyimidazo[1,2-b]pyridazin-2-yl)-2-methylphenyl)-2-naphthamide chemical structure, C25H20N4O2, CAS 946217-46-5](/s/GDDBSYFHDRQGET-UHFFFAOYSA-N.svg)
N-(5-(6-Methoxyimidazo[1,2-b]pyridazin-2-yl)-2-methylphenyl)-2-naphthamide
CAS 946217-46-5C25H20N4O2
![7-Methoxy-4-(pyridin-3-yl)-6-[2-(quinolin-2-yl)ethoxy]quinazoline chemical structure, C25H20N4O2, CAS 1006890-01-2](/s/FVMVYWKWNZLMBT-UHFFFAOYSA-N.svg)
7-Methoxy-4-(pyridin-3-yl)-6-[2-(quinolin-2-yl)ethoxy]quinazoline
CAS 1006890-01-2C25H20N4O2
N-Benzyl-2-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)-1H-indol-1-yl)acetamide
CAS 1021106-30-8C25H20N4O2
AMPK activator 11
CAS 2948304-00-3C25H20N4O2
3-Ethoxy-N-(2-naphthalen-1-ylbenzotriazol-5-yl)benzamide
CAS 292064-49-4C25H20N4O2
(3-Methoxyphenyl)(3-phenyl-5-(quinoxalin-6-yl)-4,5-dihydro-1H-pyrazol-1-yl)methanone
CAS 946361-38-2C25H20N4O2
![6-Amino-4-(2-methoxynaphthalen-1-yl)-3-methyl-1-phenyl-4H-pyrano[2,3-c]pyrazole-5-carbonitrile chemical structure, C25H20N4O2, CAS 371141-65-0](/s/RIXOULKBINGGHG-UHFFFAOYSA-N.svg)
6-Amino-4-(2-methoxynaphthalen-1-yl)-3-methyl-1-phenyl-4H-pyrano[2,3-c]pyrazole-5-carbonitrile
CAS 371141-65-0C25H20N4O2
![5-(4-Methoxyphenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one chemical structure, C25H20N4O2, CAS 425648-46-0](/s/XGJYMGFLZJCJHO-UHFFFAOYSA-N.svg)
5-(4-Methoxyphenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one
CAS 425648-46-0C25H20N4O2
![11-(3-Methoxyphenyl)-9-phenyl-8-oxa-12,13,15,17-tetraazatetracyclo[8.7.0.0^{2,7}.0^{12,16}]heptadeca-1(10),2(7),3,5,13,15-hexaene chemical structure, C25H20N4O2, CAS 868147-86-8](/s/MZMHOOYTRLOARK-UHFFFAOYSA-N.svg)
11-(3-Methoxyphenyl)-9-phenyl-8-oxa-12,13,15,17-tetraazatetracyclo[8.7.0.0^{2,7}.0^{12,16}]heptadeca-1(10),2(7),3,5,13,15-hexaene
CAS 868147-86-8C25H20N4O2
![2-(3,4-Dimethylphenyl)-4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291862-85-5](/s/OADFLHUUWOABAC-UHFFFAOYSA-N.svg)
2-(3,4-Dimethylphenyl)-4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]phthalazin-1(2H)-one
CAS 1291862-85-5C25H20N4O2
![1-Benzyl-4-oxo-N-(p-tolyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide chemical structure, C25H20N4O2, CAS 900284-61-9](/s/XMKJXKXQNMRJAO-UHFFFAOYSA-N.svg)
1-Benzyl-4-oxo-N-(p-tolyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide
CAS 900284-61-9C25H20N4O2
![N,1-dibenzyl-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide chemical structure, C25H20N4O2, CAS 900895-52-5](/s/IPXUTIABCYSYAT-UHFFFAOYSA-N.svg)
N,1-dibenzyl-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide
CAS 900895-52-5C25H20N4O2
![1-Benzyl-4-oxo-N-(m-tolyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide chemical structure, C25H20N4O2, CAS 900266-10-6](/s/HMEDGAPXPKVDAI-UHFFFAOYSA-N.svg)
1-Benzyl-4-oxo-N-(m-tolyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide
CAS 900266-10-6C25H20N4O2
![N-Benzyl-2-(4-methylphenyl)-3-oxo-2H,3H,5H-pyrazolo[4,3-c]quinoline-8-carboxamide chemical structure, C25H20N4O2, CAS 1251571-94-4](/s/UTDLTTNSZYKTNX-UHFFFAOYSA-N.svg)
N-Benzyl-2-(4-methylphenyl)-3-oxo-2H,3H,5H-pyrazolo[4,3-c]quinoline-8-carboxamide
CAS 1251571-94-4C25H20N4O2
![4-[3-(4-Ethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(3-methylphenyl)phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291857-20-9](/s/QJXANCPQEMHSLK-UHFFFAOYSA-N.svg)
4-[3-(4-Ethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(3-methylphenyl)phthalazin-1(2H)-one
CAS 1291857-20-9C25H20N4O2
![4-[3-(3,4-Dimethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(3-methylphenyl)phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291840-56-6](/s/WTTNJLYGTYOIBI-UHFFFAOYSA-N.svg)
4-[3-(3,4-Dimethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(3-methylphenyl)phthalazin-1(2H)-one
CAS 1291840-56-6C25H20N4O2
![2-(3,4-Dimethylphenyl)-4-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291863-03-0](/s/WGEICSJURURDGV-UHFFFAOYSA-N.svg)
2-(3,4-Dimethylphenyl)-4-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]phthalazin-1(2H)-one
CAS 1291863-03-0C25H20N4O2
![2-(3,4-Dimethylphenyl)-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,2-dihydrophthalazin-1-one chemical structure, C25H20N4O2, CAS 1291853-02-5](/s/NZEWCFTXOVSZAN-UHFFFAOYSA-N.svg)
2-(3,4-Dimethylphenyl)-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,2-dihydrophthalazin-1-one
CAS 1291853-02-5C25H20N4O2
![4-[3-(4-Ethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylphenyl)phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291838-55-5](/s/SARPORDFUHJOEO-UHFFFAOYSA-N.svg)
4-[3-(4-Ethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylphenyl)phthalazin-1(2H)-one
CAS 1291838-55-5C25H20N4O2
![4-[3-(3,4-Dimethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylphenyl)phthalazin-1(2H)-one chemical structure, C25H20N4O2, CAS 1291845-39-0](/s/IVNBRCLTUBIGTI-UHFFFAOYSA-N.svg)
4-[3-(3,4-Dimethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylphenyl)phthalazin-1(2H)-one
CAS 1291845-39-0C25H20N4O2
- N-(3-(4-((4-Phenoxyphenyl)amino)pyrimidin-5-yl)phenyl)acrylamide1415824-06-4C25H20N4O2
- 9-(3-Methoxyphenyl)-11-phenyl-8-oxa-12,13,15,17-tetraazatetracyclo[8.7.0.0^{2,7}.0^{12,16}]heptadeca-1(10),2(7),3,5,13,15-hexaene868147-15-3C25H20N4O2
- 6-(2-(2,4-Dimethylphenyl)-2-oxoethyl)-2-phenyl-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one1189680-67-8C25H20N4O2
- 4-[3-(4-Ethylphenyl)-1,2,4-oxadiazol-5-yl]-2-(4-methylphenyl)phthalazin-1(2H)-one1359109-39-9C25H20N4O2
- Benzyl 2-amino-1-(4-methylphenyl)pyrrolo[3,2-b]quinoxaline-3-carboxylate840496-93-7C25H20N4O2
- 8-Ethyl-3-(4-methylphenyl)-1-(3-nitrophenyl)-1H-pyrazolo[4,3-c]quinoline901265-16-5C25H20N4O2
- 4-(p-Tolyl)-2-((3-(o-tolyl)-1,2,4-oxadiazol-5-yl)methyl)phthalazin-1(2H)-one1216901-19-7C25H20N4O2
- 4-(3-(3,4-Dimethylphenyl)-1,2,4-oxadiazol-5-yl)-2-(p-tolyl)phthalazin-1(2H)-one1358791-53-3C25H20N4O2
- 2-(4-Ethylphenyl)-4-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)phthalazin-1(2H)-one1359398-27-8C25H20N4O2
- 2-(3-Benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)-N-(1H-indol-6-yl)acetamide1324063-03-7C25H20N4O2
- 3-(4-Methoxyphenyl)-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-8-amine1196389-84-0C25H20N4O2
- 6-(3,4-Dimethoxyphenyl)-2,3-diphenylimidazo[1,2-b][1,2,4]triazine696648-32-5C25H20N4O2
- 3-(3,4-Dimethylphenyl)-8-methyl-1-(3-nitrophenyl)-1H-pyrazolo[4,3-c]quinoline901004-55-5C25H20N4O2
- 2-(3-Benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)-N-(1H-indol-4-yl)acetamide1324078-27-4C25H20N4O2
- 2-(3-Benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)-N-(1H-indol-5-yl)acetamide1324072-73-2C25H20N4O2
- (E)-2-Cyano-3-[4-[(1-methylimidazol-2-yl)methoxy]phenyl]-N-naphthalen-1-ylprop-2-enamide1198059-44-7C25H20N4O2
- 4H-Imidazol-4-one, 3,5-dihydro-3-(2-(1H-benzimidazol-2-yl)phenyl)-5-((4-methoxyphenyl)methylene)-2-methyl-90660-80-3C25H20N4O2
- 7-Methyl-5-pyrazin-2-yl-2-[4-(pyridin-2-yloxy)-benzyl]-2,3-dihydro-isoindol-1-one877146-99-1C25H20N4O2
- 7-(4-Acetylphenyl)-2-ethyl-3-phenylpyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-6(7H)-one1015566-32-1C25H20N4O2
- 4H-Imidazol-4-one, 3,5-dihydro-3-(3-(1H-benzimidazol-2-yl)phenyl)-5-((4-methoxyphenyl)methylene)-2-methyl-90660-83-6C25H20N4O2
- 4,4'-(Phenylmethylene)bis(5-phenyl-2,4-dihydro-3H-pyrazol-3-one)63554-44-9C25H20N4O2
- 6-[(4-Ethenylphenyl)methyl]-2-(3-methoxyphenyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-one2380190-83-8C25H20N4O2
- N'-(2-Hydroxy-5-(naphthalen-1-yldiazenyl)benzylidene)-2-phenylacetohydrazide341974-92-3C25H20N4O2
Frequently asked questions
What is the molar mass of C25H20N4O2?
The molar mass of C25H20N4O2 is 408.46 g/mol, calculated from standard atomic weights for 25 carbon atoms, 20 hydrogen atoms, 4 nitrogen atoms and 2 oxygen atoms. The monoisotopic mass is 408.1586 Da.
How many compounds have the formula C25H20N4O2?
CompoundList lists 47 compounds with the molecular formula C25H20N4O2, including Devazepide, Tinodasertib, 3-(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)-2-phenylquinazolin-4-one. Compounds that share a formula are isomers. They contain the same atoms arranged differently, so their properties, uses and prices can be very different.
What is the degree of unsaturation of C25H20N4O2?
C25H20N4O2 has a degree of unsaturation of 18. That is the total number of rings and pi bonds (a double bond counts as one, a triple bond as two) in any structure with this formula.